LARGE MOLECULE

Absorption Systems Boston (“ASB”) is a GLP/GMP facility offering support from early drug discovery through Phase IV clinical trials. With a core competency in assay development and validation, the ASB team routinely creates robust methodologies for compound screening, product characterization, PK/PD analysis, biomarkers such as cytokines/chemokines, potency, stability, and immunogenic response (ADA, NAb) using the following techniques:

  • ELISA
  • Luminex
  • Flow Cytometry
  • Quantitative Western Blot
  • ELISpot
  • Enzyme Activity Assays
  • Fluorescent and Luminescent Assays
  • Cell Based Assays

Complementing the comprehensive array of bioanalytical and bioassay services, the ASB facility includes a research-use only vivarium suitable for housing mice, rats, hamsters, and guinea pigs. While providing flexibility in the execution of customized designs for a Sponsor, the ASB in-life team routinely performs PK and immunogenicity studies.